CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases

Objective Endometrial stromal sarcoma (ESS) is an uncommon malignant neoplasm within the female reproductive system. This tumor arises from the stromal cells of the endometrium and ranks as the second most prevalent type of malignant mesenchymal tumor in the uterus, following leiomyosarcoma. It constitutes approximately 1% of all female genital tract cancers and accounts for 3–9% of uterine neoplasms. The clinical specificity of ESS is poor, its imaging manifestations are diverse, and early diagnosis is difficult, relying on pathological confirmation. Methods In this retrospective single-center study, we analyzed the CT and MRI imaging findings of 35 pathologically confirmed ESS cases (26 low-grade, 9 high-grade) to identify characteristic imaging features and subgroup differences. Results Key findings included the uterine rupture/channel sign (observed in 7 of 21 endometrial-involved cases), honeycomb-like vascular shadows (5 cases), and progressive centripetal homogeneous enhancement (2 cases). Low grade ESS tended to present with larger tumors and more frequent extensive pelvic invasion (mean diameter 10.76 ± 6.58 cm vs. 6.57 ± 1.51 cm, P = 0.007), while high grade ESS more commonly presented with abdominal pain (P = 0.013) and elevated CA19-9 (P = 0.013). Conclusion These imaging signs may provide auxiliary clues for preoperative suspicion of ESS; however, definitive diagnosis remains dependent on postoperative pathology and immunohistochemistry. Due to the single-center design, small sample size, and lack of a control group, the diagnostic specificity of these signs requires further validation in multicenter prospective studies.

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-10-29
DOI
https://doi.org/10.3389/fonc.2026.1847673
Primary Topic
Uterine Myomas and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases

Haiyan Gu, Liling Long, Lan Yu, Meizhen Xie et al.
1 links
Frontiers in Oncology
Uterine Myomas and Treatments
article

CT and MRI multimodality imaging features of endometrial stromal sarcoma: a retrospective single-center analysis of 35 pathologically confirmed cases

Haiyan Gu, Liling Long, Lan Yu, Meizhen Xie, Yan Dong, Xiaoming Zhou
article en

Abstract

Objective Endometrial stromal sarcoma (ESS) is an uncommon malignant neoplasm within the female reproductive system. This tumor arises from the stromal cells of the endometrium and ranks as the second most prevalent type of malignant mesenchymal tumor in the uterus, following leiomyosarcoma. It constitutes approximately 1% of all female genital tract cancers and accounts for 3–9% of uterine neoplasms. The clinical specificity of ESS is poor, its imaging manifestations are diverse, and early diagnosis is difficult, relying on pathological confirmation. Methods In this retrospective single-center study, we analyzed the CT and MRI imaging findings of 35 pathologically confirmed ESS cases (26 low-grade, 9 high-grade) to identify characteristic imaging features and subgroup differences. Results Key findings included the uterine rupture/channel sign (observed in 7 of 21 endometrial-involved cases), honeycomb-like vascular shadows (5 cases), and progressive centripetal homogeneous enhancement (2 cases). Low grade ESS tended to present with larger tumors and more frequent extensive pelvic invasion (mean diameter 10.76 ± 6.58 cm vs. 6.57 ± 1.51 cm, P = 0.007), while high grade ESS more commonly presented with abdominal pain (P = 0.013) and elevated CA19-9 (P = 0.013). Conclusion These imaging signs may provide auxiliary clues for preoperative suspicion of ESS; however, definitive diagnosis remains dependent on postoperative pathology and immunohistochemistry. Due to the single-center design, small sample size, and lack of a control group, the diagnostic specificity of these signs requires further validation in multicenter prospective studies.

Frontiers in OncologyVol. 16
Guangxi Medical University (CN), Guilin Medical University (CN), Affiliated Hospital of Qingdao University (CN), First Affiliated Hospital of GuangXi Medical University (CN), Affiliated Hospital of Guilin Medical College (CN)
Good health and well-being
Openalex Percentile: Top 8%
Uterine Myomas and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon